You just read:

AbbVie Receives Health Canada Approval of RINVOQ® (upadacitinib), an Oral Medication for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis

News provided by

AbbVie Canada

Jan 07, 2020, 08:01 ET